1. Clinical Overview
Tamsulosin is a selective, long-acting alpha-1A and alpha-1D adrenergic receptor antagonist. It is a first-line medical therapy for the symptomatic treatment of Benign Prostatic Hyperplasia (BPH) in the Indian context. It works by relaxing smooth muscle in the prostate and bladder neck, improving urine flow and reducing symptoms of obstruction and irritation without significantly affecting blood pressure.
| Onset | Duration | Bioavailability |
|---|---|---|
| Onset of symptom relief is typically within 1-2 weeks, with peak clinical effect observed after 4-6 weeks of continuous therapy. | Approximately 24 hours, supporting once-daily dosing. | Approximately 100% under fasting conditions. Food reduces bioavailability by 30-40%. |
2. Mechanism of Action
Tamsulosin selectively and competitively blocks postsynaptic alpha-1A (approximately 70% of prostatic alpha-1 receptors) and alpha-1D adrenoceptors located in the smooth muscle of the prostate, prostatic capsule, prostatic urethra, and bladder neck. This blockade inhibits the action of endogenous catecholamines (noradrenaline), leading to relaxation of smooth muscle, a decrease in urethral resistance, and improved urinary flow.
3. Indications & Uses
- Symptomatic treatment of Benign Prostatic Hyperplasia (BPH/LUTS)
4. Dosage & Administration
Adult Dosage: 0.4 mg once daily, taken 30 minutes after the same meal each day. Dose can be increased to 0.8 mg once daily if response is inadequate after 2-4 weeks.
Administration: Swallow the capsule whole with a glass of water. Do not crush, chew, or open the capsule. Take approximately 30 minutes after the same meal (e.g., breakfast or dinner) every day to ensure consistent absorption and reduce risk of dizziness/orthostasis.
5. Side Effects
Common side effects may include:
- Abnormal ejaculation/retrograde ejaculation (8-18%)
- Dizziness (3-10%)
- Headache (3-5%)
- Rhinitis/Nasal congestion
- Asthenia (weakness)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Alpha-1 Blockers (e.g., Prazosin, Doxazosin, Terazosin) | Additive hypotensive and syncopal effects. | Major |
| Phosphodiesterase-5 Inhibitors (e.g., Sildenafil, Tadalafil) | Potential additive blood pressure-lowering effects, may cause symptomatic hypotension. | Major |
| Strong CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Ritonavir, Clarithromycin) | May significantly increase tamsulosin plasma concentrations, increasing adverse effects. | Major |
| Moderate CYP3A4 Inhibitors (e.g., Erythromycin, Diltiazem, Verapamil) | May increase tamsulosin levels. Monitor for adverse effects. | Moderate |
| Warfarin | Tamsulosin is highly protein-bound; potential for displacement interaction, though not consistently reported. Monitor INR. | Moderate |
| Antihypertensives (e.g., Beta-blockers, ACE Inhibitors, Diuretics) | Potential additive blood pressure-lowering effect, increasing risk of dizziness/orthostasis. | Moderate |
| Cimetidine | May moderately increase tamsulosin exposure. | Moderate |
7. Patient Counselling
- DO take the capsule 30 minutes after the same meal every day.
- DO swallow the capsule whole with a full glass of water.
- DO inform all your doctors, especially your eye surgeon, that you are taking this medicine.
- DO NOT crush, chew, or open the capsule.
- DO NOT take the dose on an empty stomach.
- DO NOT stop taking the medicine without consulting your doctor, even if you feel better.
8. Toxicology & Storage
Overdose: Severe hypotension (marked dizziness, fainting), tachycardia, headache, vomiting, blurred vision. Priapism is a theoretical risk.
Storage: Store below 30°C. Protect from light and moisture. Keep out of reach of children.